These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation]. Wang SH Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342 [TBL] [Abstract][Full Text] [Related]
43. Multiple and recurrent epithelial tumors of the bladder in a child. Li R; Kim K; Brendler H J Urol; 1972 Oct; 108(4):644-6. PubMed ID: 4631254 [No Abstract] [Full Text] [Related]
44. Intravesical and systemic chemotherapy in the management of superficial bladder cancer. Soloway MS Urol Clin North Am; 1984 Nov; 11(4):623-35. PubMed ID: 6438857 [TBL] [Abstract][Full Text] [Related]
45. [Prevention of the recurrence of bladder tumors with local adriamycin therapy]. Somogyi L; Török A; Bors G; Frang D Orv Hetil; 1984 Oct; 125(41):2503-6. PubMed ID: 6493764 [No Abstract] [Full Text] [Related]
46. [Clinical-experience with thiotepa in the treatment of bladder cancer]. Gallo FJ; Menéndez-Ondina L; Matallana A; Bonilla JA; Serrano E; Carballido JA; Mendoza A Actas Urol Esp; 1978; 2(5):237-40. PubMed ID: 103371 [No Abstract] [Full Text] [Related]
47. The use of chemotherapeutic agents in the prophylaxis of papillary bladder tumours. Pavone-Macaluso M; Caramia G; Rizzo FP Urol Int; 1971; 26(5):379-87. PubMed ID: 5136749 [No Abstract] [Full Text] [Related]
51. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer]. Hofmann W; Langkopf B Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737 [No Abstract] [Full Text] [Related]
52. Point. Routine use of postoperative intravesical chemotherapy after TURBT-should it be done? Soloway MS; Arianayagam M Urology; 2010 Oct; 76(4):794-6. PubMed ID: 20932403 [No Abstract] [Full Text] [Related]
53. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma]. Zhang SX; Deng XZ; Tang XD Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180 [No Abstract] [Full Text] [Related]
54. Absorption of drugs from the bladder and intravesical chemotherapy. Pavone-Macaluso M; Gebbia N Urol Res; 1976 Apr; 4(1):1-3. PubMed ID: 821198 [No Abstract] [Full Text] [Related]
55. Experimental techniques for testing the sensitivity of bladder tumours to antineoplastic drugs. Pavone-Macaluso M; Gebbia N; Biondo F; Rizzo FP; Caramia G; Rausa L Urol Res; 1973 May; 1(2):60-6. PubMed ID: 4204526 [No Abstract] [Full Text] [Related]
56. [Urinary bladder neoplasms]. Shinohara N Gan To Kagaku Ryoho; 2009 Jan; 36(1):38-42. PubMed ID: 19195117 [No Abstract] [Full Text] [Related]
57. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients]. Llopis B; Gallego J; Boronat F; Moreno B; Mompó JA; Jiménez JF Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589 [No Abstract] [Full Text] [Related]
58. [The so-called benign tumors of the urinary tract]. Rutishauser G; Klein U Helv Chir Acta; 1973 Dec; 40(5):667-77. PubMed ID: 4203748 [No Abstract] [Full Text] [Related]
59. Clinical trials in superficial and invasive bladder cancer. Smith PH Turk J Pediatr; 1984; 26(1-4):251-63. PubMed ID: 6443168 [No Abstract] [Full Text] [Related]
60. [The intravesical chemotherapy of surface tumors of the bladder]. Matveev BP; Figurin KM; Romanov VA; Burnaz AO Urol Nefrol (Mosk); 1992; (4-6):13-5. PubMed ID: 1475868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]